Tongfeng Chen

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Chemotherapy Induced

Small Cell Lung Cancer

Radiofrequency Ablation

Left Ventricular

Top Venues

Cardiovascular therapeutics

Clinical cardiology

This page only lists publications with an associated author ORCID identifier.

Publications

Ziying Zhao, Tongfeng Chen, Zhen Zhou, Rui Guo, Qiao Liu
Cost-effectiveness of camrelizumab combined with chemotherapy in the first-line treatment of recurrent or metastatic nasopharyngeal carcinoma in China. BMJ open 13 (12) (2023)
Ziying Zhao, Tongfeng Chen, Zhen Zhou, Rui Guo, Qiao Liu
Cost-effectiveness of camrelizumab combined with chemotherapy in the first-line treatment of recurrent or metastatic nasopharyngeal carcinoma in China. BMJ open 13 (12) (2023)
Tongfeng Chen, Yuhao Liu, Jing Zhang, Zirui Sun, Yu Han, Chuanyu Gao
Percutaneous closure of ventricular septal rupture after myocardial infarction: A retrospective study of 81 cases. Clinical cardiology (2023)
Ziying Zhao, Tongfeng Chen, Zhen Zhou, Rui Guo, Qiao Liu
Cost-effectiveness of camrelizumab combined with chemotherapy in the first-line treatment of recurrent or metastatic nasopharyngeal carcinoma in China. BMJ open 13 (12) (2023)
Ziying Zhao, Tongfeng Chen, Zhen Zhou, Rui Guo, Qiao Liu
Cost-effectiveness of camrelizumab combined with chemotherapy in the first-line treatment of recurrent or metastatic nasopharyngeal carcinoma in China. BMJ open 13 (12) (2023)
Tongfeng Chen, Yuhao Liu, Jing Zhang, Zirui Sun, Jiangtao Cheng, Yu Han, Chuanyu Gao
Comparison between Cardiac CTA and Echocardiography for Assessment of Ventricular Septal Rupture Diameter and Its Effect on Transcatheter Closure. Cardiovascular therapeutics 2022 (2022)